Novartis Investigative site

Sihhiye/Ankara 06100

0 studies enrolling now · 3 studies all time

What they study most

Acute Gout, Non-small Cell Lung Cancer, Parkinson's Disease Dementia

Studies at this site

• This Study Will Evaluate the Effect of Canakinumab or Pembrolizumab Given as Monotherapy or in Combination as Neo-adjuvant Treatment for Subjects With Early Stages NSCLC. — Stopped early
• Targeted Dose Finding of Canakinumab (ACZ885) for Management of Acute Flare in Refractory or Contraindicated Gout Patients — Completed
• Long-term Safety of Rivastigmine Capsule and Patch in Patients With Mild to Moderately-severe Dementia Associated With Parkinson's Disease (PDD) — Completed